Is India Signatory To Nagoya Protocol?
The Nagoya Protocol is supplementary to the United Nations Convention on Biological Diversity (UNCBD). It is an important international treaty with India being a party to it. Environmental treaties and protocols are very important for the IAS exam. This protocol is a legal framework for the implementation of one of the objectives of the Convention on Biological Diversity, which is the fair & equitable sharing of benefits arising out of the utilization of genetic resources. The protocol was adopted in 2010 in Nagoya, Japan. The objective of the protocol is the fair and equitable sharing of benefits coming from the utilization of genetic resources and helping in the conservation & sustainable usage of biodiversity. The protocol creates obligations for members to incorporate measures in respect of access to genetic resources, sharing of benefits, and compliance. It is one of the important environmental protocols of the world. The Nagoya Protocol is significant in terms of conservation of biodiversity, and for having an equitable sharing of benefits of the genetic resources.
This is also intended to help indigenous peoples everywhere to avoid being exploited for their traditional knowledge and expertise. This protocol will help both the users and the owners of genetic resources by creating better legal certainty and transparency in the following ways: It sets more predictable conditions for access to genetic resources. It helps in having a better benefit-sharing experience when the genetic resources travel outside the country of origin. The parties to the protocol are obliged to take actions with respect to access to genetic resources, benefit-sharing, and compliance. Access measures should have legal certainty, transparency, and clarity. The rules and Medi Bloom CBD Review procedures thereof should be fair and non-arbitrary. There should be clear rules for prior informed consent and mutually agreed to terms. The rules should have provisions for the issuance of a permit (or its equivalent) when granted access. Encourage research that will contribute to the conservation of biodiversity and its sustainable use.
Cases of imminent emergencies that threaten plant, animal, or human health should be considered. Take into consideration the importance of genetic resources for food and agriculture, to have food security. Benefit-sharing measures should have provisions for the fair & equitable sharing of benefits that arise from the utilization of genetic resources with the contracting party that provides genetic resources. Utilization implies R&D on the biochemical or genetic composition of genetic resources, and also resultant applications & commercialization. Sharing should be subject to mutually-agreed terms. Benefits could be non-monetary or monetary. Benefits could be in the form of royalties and/or sharing of the results of the research. This includes having legal provisions for the implementation of the protocol. This also includes having dispute resolution mechanisms in place for resolving any disputes. India signed the Nagoya Protocol in 2011 and ratified it in October 2012. The ratification by India was done at the 11th Conference of Parties (COP) to the CBD, which was conducted in Hyderabad. Is Nagoya Protocol legally binding? Yes, it is legally binding. Is India signatory to Nagoya Protocol? Yes, Medi Bloom CBD Supplement India is a signatory to the Protocol. What is the Aichi target? The 10th COP of the Medi Bloom CBD Review was held in the precinct of Aichi, at Nagoya. It is here that the Nagoya Protocol and the Aichi Targets were adopted. The Aichi targets refer to five strategic goals that are concerned with biodiversity.
By Rebecca Lake. January 27, 2025 · This content may include information about products, features, and/or services that SoFi does not provide and is intended to be educational in nature. Cannabis ETFs are funds that concentrate their holdings in the cannabis or marijuana industry. Investing in a single weed ETF could allow you to gain exposure to dozens of cannabis-related companies, without having to buy individual stocks. As such, you might consider adding a cannabis ETF to your portfolio if you’re looking for diversification, as exchange-traded funds or ETFs may offer exposure to a collection of investments in a single basket. Investors should learn more about ETFs as investments, and the specifics of the marijuana industry, however, before investing. • Cannabis ETFs offer diversification and potential returns in a growing industry. • Higher volatility and legal, regulatory challenges in the cannabis sector can pose significant investment risks. • Cannabis ETF selection factors may include expense ratio, holdings, trading volume, liquidity, and regulatory compliance.
• A handful of issuing companies provide some of the more popular U.S. • Investors should also consider minimum investment, share price, and custodian availability. What Are Cannabis ETFs? Cannabis ETFs are exchange-traded funds that invest in companies that are connected to the cannabis industry. A marijuana ETF works the same way as any other type of ETF, in terms of how it’s traded, as they can be bought and sold on the stock market. As for how they work, ETFs pool money from multiple investors and trade on an exchange. All that sets a cannabis ETF apart from other ETFs is what it invests in - in this case, the cannabis industry. There are only a handful of cannabis ETFs that trade in the U.S. The world’s first marijuana ETF, Global X Marijuana Life Sciences Index (HMMJ) was launched in Canada in 2017. The first U.S.-focused cannabis ETF landed in 2020, with the introduction of AdvisorShares’ Pure US Cannabis ETF (MSOS).